医学
乳腺癌
卵巢癌
肿瘤科
内科学
癌症
突变
妇科
遗传学
基因
生物
作者
Karoline Kuchenbaecker,John L. Hopper,Daniel R. Barnes,Kelly‐Anne Phillips,Thea M. Mooij,Marie-José Roos-Blom,Sarah Jervis,Flora E. van Leeuwen,Roger L. Milne,Nadine Andrieu,David E. Goldgar,Mary Beth Terry,Matti A. Rookus,Douglas F. Easton,Antonis C. Antoniou,Lesley McGuffog,D. Gareth Evans,Daniel Barrowdale,Debra Frost,Julian Adlard
出处
期刊:JAMA
[American Medical Association]
日期:2017-06-20
卷期号:317 (23): 2402-2402
被引量:2754
标识
DOI:10.1001/jama.2017.7112
摘要
These findings provide estimates of cancer risk based on BRCA1 and BRCA2 mutation carrier status using prospective data collection and demonstrate the potential importance of family history and mutation location in risk assessment.
科研通智能强力驱动
Strongly Powered by AbleSci AI